HEALTHCO HEALTHCARE & WELLNESS REIT (HCW)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

HCW

HCW - HEALTHCO HEALTHCARE & WELLNESS REIT

FNArena Sector : REITs
Year End: June
GICS Industry Group : Real Estate
Debt/EBITDA: 12.42
Index: ASX300 | ALL-ORDS

LAST PRICE CHANGE +/- CHANGE % VOLUME

$0.715

10 Sep
2025

-0.005

OPEN

$0.72

-0.69%

HIGH

$0.73

2,994,853

LOW

$0.71

TARGET
$0.888 24.1% upside
OTHER COMPANIES IN THE SAME SECTOR
ABG . AOF . ARF . ASK . BWP . CDP . CDP . CHC . CIP . CLW . COF . CQE . CQR . DGT . DXC . DXI . DXS . ECF . GDF . GDI . HDN . NSR . PLG . REP . RFF . RGN . SCG . TGP . VCX . WOT . WPR .
FNARENA'S MARKET CONSENSUS FORECASTS
HCW: 1
Title FY24
Actual
FY25
Actual
FY26
Forecast
FY27
Forecast
EPS (cps) xxx - 16.0 8.9 xxx
DPS (cps) xxx 0.0 3.7 xxx
EPS Growth xxx N/A N/A xxx
DPS Growth xxx N/A N/A xxx
PE Ratio xxx N/A 8.2 xxx
Dividend Yield xxx N/A 5.1% xxx
Div Pay Ratio(%) xxx N/A 41.8% xxx

Dividend yield today if purchased 3 years ago: 0.00%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

0.00

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 30/12 - (franking ex-di

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2025 FactSet UK Limited. All rights reserved
Title 202320242025
EPS Basic xxxxxx-16.0
DPS All xxxxxx0.0
Sales/Revenue xxxxxx61.5 M
Book Value Per Share xxxxxx143.2
Net Operating Cash Flow xxxxxx33.2 M
Net Profit Margin xxxxxx-144.39 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202320242025
Return on Capital Employed xxxxxx-10.44 %
Return on Invested Capital xxxxxx-8.13 %
Return on Assets xxxxxx-6.54 %
Return on Equity xxxxxx-10.44 %
Return on Total Capital xxxxxx2.73 %
Free Cash Flow ex dividends xxxxxx-1.4 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202320242025
Short-Term Debt xxxxxx445 M
Long Term Debt xxxxxx3 M
Total Debt xxxxxx448 M
Goodwill - Gross xxxxxx-
Cash & Equivalents - Generic xxxxxx41 M
Price To Book Value xxxxxx0.51

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202320242025
Capex xxxxxx0.0 M
Capex % of Sales xxxxxx0.00 %
Cost of Goods Sold xxxxxx17 M
Selling, General & Admin. Exp & Other xxxxxx9 M
Research & Development xxxxxx-
Investments - Total xxxxxx890 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.3

No. Of Recommendations

4
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Morgans

xx/xx/xxxx

3

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgan Stanley

xx/xx/xxxx

5

xxxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Bell Potter

18/08/2025

1

Buy

$1.00

39.86%

HealthCo Healthcare & Wellness REIT reported its FY25 result with funds from operations (FFO) of 6.6cpu, which was -17% below Bell Potter’s forecast and -16% below consensus.

These misses were driven by the suspension of distributions in the second half by the Unlisted Healthco Fund (UHF), explain the analysts.

No FY26 guidance was provided, with distributions to recommence once the Healthscope situation is resolved.

HealthCo and UHF continue to work with the receiver on the Healthscope sale process to secure a new tenant. 

The broker notes all eleven Healthscope hospitals remain operational and full rent has been paid, while a receiver-led sale process is underway to replace Healthscope as tenant. If unsuccessful, Healthco and UHF are preparing alternative lease arrangements.

The broker highlights asset sales of $80m reduced gearing to 31.1%, within the 30-40% target range, supported by cash and undrawn debt of around $104m, though interest cover is under closer watch given UHF.

Bell Potter cuts its FY26-28 earnings forecasts by between -37% to -7%, sets its target price at $1.00, down from $1.15 and retains a Buy rating.

FORECAST
Bell Potter forecasts a full year FY26 dividend of 2.10 cents.
Bell Potter forecasts a full year FY27 dividend of 7.30 cents.

Macquarie

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

0

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

HCW STOCK CHART